5 Best Guru Stocks To Buy Now

2. Repare Therapeutics Inc. (NASDAQ:RPTX)

Number of Hedge Fund Holders: 11

Percentage of Guru Index ETF’s Net Assets as of October 18: 1.77%

Repare Therapeutics Inc. (NASDAQ:RPTX) is headquartered in Montreal, Canada, operating as a clinical-stage precision oncology company that develops therapeutics using its synthetic lethality approach in Canada and the United States. Guru ETF owns 59,021 shares of Repare Therapeutics Inc. (NASDAQ:RPTX), worth $804.45 million and representing 1.77% of the total portfolio. 

On June 6, H.C. Wainwright analyst Robert Burns reiterated a Buy recommendation on Repare Therapeutics Inc. (NASDAQ:RPTX) but lowered the price target on the shares to $38 from $54. The licensing agreement with Roche provides external validation for RP-3500, the analyst told investors in a bullish thesis.

Among the hedge funds tracked by Insider Monkey, 11 funds reported owning stakes worth $273.2 million in Repare Therapeutics Inc. (NASDAQ:RPTX) at the end of Q2 2022, compared to 13 funds in the prior quarter worth $261 million. Mark Lampert’s Biotechnology Value Fund BVF Inc is the leading position holder in the company, with 8.3 million shares valued at $116 million.